Intense Pulsed Light Therapy with Optimal Pulse Technology as an Adjunct Therapy for Moderate to Severe Blepharitis-Associated Keratoconjunctivitis

PURPOSE: To evaluate the intense pulsed light (IPL) therapy with optimal pulse technology (OPT, M22™, Lumenis, USA) as an adjunct therapy for the prevention of recurrences in moderate to severe blepharokeratoconjunctivitis (BKC). METHODS: This open-label nonrandomized clinical trial evaluated 33 pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Ophthalmol
Main Authors: Ruan, Fang, Zang, Yunxiao, Sella, Ruti, Lu, Hongshuang, Li, Shang, Yang, Ke, Jin, Tao, Afshari, Natalie A., Pan, Zhiqiang, Jie, Ying
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6766164/
https://ncbi.nlm.nih.gov/pubmed/31637051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3143469
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados